×
ZimVie SG&A Expenses 2019-2024 | ZIMV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
ZimVie sg&a expenses from 2019 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
ZimVie SG&A Expenses 2019-2024 | ZIMV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
ZimVie sg&a expenses from 2019 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$195.6B
Stryker (SYK)
$137.3B
Boston Scientific (BSX)
$122.7B
Medtronic (MDT)
$114.6B
EssilorLuxottica (ESLOY)
$108.8B
Haleon (HLN)
$48.7B
Lonza Group Ag (LZAGY)
$46B
ResMed (RMD)
$35.1B
Koninklijke Philips (PHG)
$30.8B
Terumo (TRUMY)
$28.5B
Zimmer Biomet Holdings (ZBH)
$22B
Baxter (BAX)
$19.9B
Insulet (PODD)
$16.3B
Smith & Nephew SNATS (SNN)
$13.6B
Bio-Rad Laboratories (BIO)
$9.2B
Demant (WILYY)
$8.7B
BellRing Brands (BRBR)
$7.9B
Lantheus Holdings (LNTH)
$7.5B
ICU Medical (ICUI)
$4.3B
Haemonetics (HAE)
$4.1B
TG Therapeutics (TGTX)
$3.7B
Neogen (NEOG)
$3.6B
Prestige Consumer Healthcare (PBH)
$3.5B
GN Store Nord (GNNDY)
$3.5B
Perrigo (PRGO)
$3.5B
Envista Holdings (NVST)
$3.4B
QuidelOrtho (QDEL)
$3.1B
Agios Pharmaceuticals (AGIO)
$2.6B
Green Thumb Industries (GTBIF)
$2.2B
Maravai LifeSciences Holdings (MRVI)
$2.1B